1. Home
  2. WILC vs YMAB Comparison

WILC vs YMAB Comparison

Compare WILC & YMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WILC
  • YMAB
  • Stock Information
  • Founded
  • WILC 1994
  • YMAB 2015
  • Country
  • WILC Israel
  • YMAB United States
  • Employees
  • WILC N/A
  • YMAB N/A
  • Industry
  • WILC Food Distributors
  • YMAB Biotechnology: Pharmaceutical Preparations
  • Sector
  • WILC Consumer Discretionary
  • YMAB Health Care
  • Exchange
  • WILC Nasdaq
  • YMAB Nasdaq
  • Market Cap
  • WILC 225.4M
  • YMAB 192.4M
  • IPO Year
  • WILC 1997
  • YMAB 2018
  • Fundamental
  • Price
  • WILC $15.98
  • YMAB $4.60
  • Analyst Decision
  • WILC
  • YMAB Buy
  • Analyst Count
  • WILC 0
  • YMAB 11
  • Target Price
  • WILC N/A
  • YMAB $17.55
  • AVG Volume (30 Days)
  • WILC 3.5K
  • YMAB 226.0K
  • Earning Date
  • WILC 05-19-2025
  • YMAB 05-13-2025
  • Dividend Yield
  • WILC 3.64%
  • YMAB N/A
  • EPS Growth
  • WILC 80.33
  • YMAB N/A
  • EPS
  • WILC 1.37
  • YMAB N/A
  • Revenue
  • WILC $157,003,357.00
  • YMAB $88,658,000.00
  • Revenue This Year
  • WILC N/A
  • YMAB N/A
  • Revenue Next Year
  • WILC N/A
  • YMAB $16.03
  • P/E Ratio
  • WILC $11.62
  • YMAB N/A
  • Revenue Growth
  • WILC 10.73
  • YMAB 4.92
  • 52 Week Low
  • WILC $8.18
  • YMAB $3.55
  • 52 Week High
  • WILC $17.58
  • YMAB $16.11
  • Technical
  • Relative Strength Index (RSI)
  • WILC 55.42
  • YMAB 56.43
  • Support Level
  • WILC $15.64
  • YMAB $3.99
  • Resistance Level
  • WILC $16.55
  • YMAB $5.00
  • Average True Range (ATR)
  • WILC 0.39
  • YMAB 0.35
  • MACD
  • WILC 0.03
  • YMAB 0.10
  • Stochastic Oscillator
  • WILC 53.66
  • YMAB 70.47

About WILC G. Willi-Food International Ltd.

G. Willi-Food International Ltd is a company engaged in high-quality, great-tasting kosher food products. The Company is engaged, directly and through subsidiaries, with one segment Import-export, marketing, and distribution of food products. The principal product line includes Canned Vegetables and Pickles, Canned Fish, Canned Fruit, Edible Oils, Dairy and Dairy Substitute Products, Dried Fruit, Nuts and Beans, and Other Products. Its brands include Willi-Food, Euro European Dairies, Donna Rozza, Manchow, Gold Frost, Tifeeret, The Chef Dish, Art Coffe, Mr. Chang, Muchi, Euro Butter, Euro Spread, Euro Cheese, Euro Cream, Euro Dessert, Euro Veg, Ha-Bulgaria, Gelato, and Emma.

About YMAB Y-mAbs Therapeutics Inc.

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.

Share on Social Networks: